Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
COVID-19
Biotech
FDA puts Novavax's phase 3 plan on hold for pair of vaccines
A phase 2 trial wrapped up in July 2023, with the “spontaneous” report of a patient developing motor neuropathy received last month.
James Waldron
Oct 16, 2024 9:10am
COVID antibodies shut down variants, earn $35M BARDA bucks
Oct 9, 2024 2:00pm
FDA clears at-home COVID/flu combo test with eye on fall season
Oct 8, 2024 11:05am
Nasal spray protects mice from deadly flu
Oct 2, 2024 8:54am
Atea's COVID antiviral fails to halt hospitalizations in phase 3
Sep 13, 2024 10:10am
Pfizer, BioNTech combo mRNA shot latest to lose to flu strain B
Aug 16, 2024 8:25am
More News
'Mini-lungs' reveal COVID's activity and the lung's immunity
Aug 7, 2024 11:32am
Drug prevents COVID symptoms in mice by protecting mitochondria
Jul 16, 2024 4:00am
Infinity Pharma cancer drug stops COVID, MRSA damage in mice
Jul 9, 2024 7:00am
'Active' vaccine adjuvant boosts COVID, flu antibodies in mice
Jul 9, 2024 4:00am
See more stories